| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 03/23/2011 | EP2296653A1 Compounds and methods for treating inflammatory and fibrotic disorders |
| 03/23/2011 | EP2076260B1 N-methylaminomethyl isoindole compounds and compositions comprising and methods of using the same |
| 03/23/2011 | EP1896417B1 Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 03/23/2011 | CN1942436B Lysine based compounds |
| 03/23/2011 | CN101990536A Pyrollidine-based compounds |
| 03/23/2011 | CN101990535A Benzofurane, benzothiophene, benzothiazol derivatives as fxr modulators |
| 03/23/2011 | CN101990534A Treating and preventing viral infections |
| 03/23/2011 | CN101987845A Preparation method of coumarin-7 |
| 03/23/2011 | CN101175751B Crystal of indole derivative having piperidine ring and process for production thereof |
| 03/22/2011 | US7910731 Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
| 03/22/2011 | US7910614 Azolylmethyloxiranes, use thereof for controlling plant pathogenic fungi, and agents containing the same |
| 03/22/2011 | US7910591 e.g. 3-[4-(4-Pyridine-2-yl-piperazine-1-yl)-butyl]-1,3-dihydro-2H-indol-2-one; serotonin 5-HT7 and alpha 1 receptors modulator; antxiolytic agent, antidepressant; neurodegenerative diseases; schizophrenia, Alzheimer's disease, stroke, dementias; side effect reduction |
| 03/22/2011 | US7910590 Cyclic amine bace-1 inhibitors having a heterocyclic substituent |
| 03/22/2011 | US7908735 Method and installation means for installing an electrical machine |
| 03/22/2011 | CA2632771C Substituted imidazoles and their use as pesticides |
| 03/22/2011 | CA2478229C Pyridinoylpiperidines as 5-ht1f agonists |
| 03/22/2011 | CA2432572C Oxybenzamides derivatives as factor xa inhibitors |
| 03/17/2011 | WO2011031658A1 Herbicidal pyrimidone derivatives |
| 03/17/2011 | WO2011030991A1 Furan-based curable compound derived from biomass, solvent-free curable composition, and method for preparing same |
| 03/17/2011 | WO2011030865A1 Substituted zenzyl compounds |
| 03/17/2011 | WO2011029920A1 Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
| 03/17/2011 | WO2011029808A1 Hsl inhibitors useful in the treatment of diabetes |
| 03/17/2011 | WO2011029633A1 Heterocyclic mglu5 antagonists |
| 03/17/2011 | WO2011029537A1 Sustituted ( heteroarylmethyl ) thiohydantoins as anticancer drugs |
| 03/17/2011 | WO2011006803A8 3-0x0-2, 3, -dihydro-1h-isoindole-4-carboxamides with selective parp-1 inhibition |
| 03/17/2011 | WO2010028776A8 Piperazine derivatives for binding and imaging amyloid plaques and their use |
| 03/17/2011 | US20110065768 Non-steroidal androgens compounds |
| 03/17/2011 | US20110065713 Benzazole Derivatives, Compositions, and Methods of Use as B-Secretase Inhibitors |
| 03/17/2011 | US20110065710 Insecticidal N-(Heteroarylalkyl)Alkanediamine Derivatives |
| 03/17/2011 | US20110065706 Therapeutic Agents 812 |
| 03/17/2011 | US20110065690 Compositions and methods for treatment of leukemia |
| 03/17/2011 | US20110065685 Novel indoles are cannabinoid receptor ligands |
| 03/17/2011 | US20110064698 Hepatitis c virus inhibitors |
| 03/17/2011 | US20110064696 Hepatitis c virus inhibitors |
| 03/17/2011 | US20110064695 Hepatitis c virus inhibitors |
| 03/17/2011 | US20110061723 Dye sensitised solar cell |
| 03/17/2011 | CA2773591A1 Substituted (heteroarylmethyl) thiohydantoins as anticancer drugs |
| 03/17/2011 | CA2772697A1 Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease |
| 03/17/2011 | CA2771588A1 Herbicidal pyrimidone derivatives |
| 03/17/2011 | CA2771452A1 Hsl inhibitors useful in the treatment of diabetes |
| 03/16/2011 | EP2295442A2 Inhibitors of interleukin-1beta converting enzyme |
| 03/16/2011 | EP2295429A1 3-((hetero)aryl)-indazoles as Liver X receptor (LXR) and Th-1 inhibitors for the treatment of cardiovascular diseases |
| 03/16/2011 | EP2295427A1 Substituted pyrazolyl urea derivatives useful in the treatment of cancer |
| 03/16/2011 | EP2295426A1 Substituted pyrazolyl urea derivatives useful in the treatment of cancer |
| 03/16/2011 | EP2295416A2 Triazole compounds that modulate HSP90 activity |
| 03/16/2011 | EP2295414A1 Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof |
| 03/16/2011 | EP2295413A1 Indazole compounds useful as protein kinase inhibitors |
| 03/16/2011 | EP2295412A1 Indazole compounds useful as protein kinase inhibitors |
| 03/16/2011 | EP2295408A1 Matrix metalloproteinase inhibitors |
| 03/16/2011 | EP2295138A2 Apparatus for the production of 11c methyl iodide |
| 03/16/2011 | EP2295053A1 Novel 2H-chromen-2-one-3-carboxamides for medical uses |
| 03/16/2011 | EP2294053A2 Glucokinase activators |
| 03/16/2011 | EP2132194B1 Substituted isoquinolines and their use as rho-kinase inhibitors |
| 03/16/2011 | EP1940827B1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 03/16/2011 | EP1703906B1 Immuno inhibitory pyrazolone compounds |
| 03/16/2011 | EP1699761B1 Cb1 modulator compounds |
| 03/16/2011 | EP1495018B3 Tricyclic thrombin receptor antagonists |
| 03/16/2011 | EP1448535B1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 03/16/2011 | CN101103024B Pyrimidine compound crystal or amorphous form and process for producing the same |
| 03/15/2011 | US7906653 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 03/15/2011 | US7906644 2,4-pyrimidinediamine compounds and their uses |
| 03/15/2011 | US7906629 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 03/15/2011 | US7906513 Prevent reproduction; breaking life cycle;viricides |
| 03/15/2011 | US7906512 3,6-substituted imidazol[1,2-b]pyridazine analogs for treating allergic and inflammatory diseases |
| 03/15/2011 | US7906502 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 03/15/2011 | US7906235 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials |
| 03/15/2011 | CA2630665C Heterocyclic compound having inhibitory activity on 11-.beta.-hydroxysteroid dehydrogenase type i |
| 03/15/2011 | CA2591053C Pyrimidinone compounds and preparation and use thereof |
| 03/15/2011 | CA2471814C Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient |
| 03/15/2011 | CA2431160C Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 03/15/2011 | CA2379575C Pharmaceutically active sulfonamide derivatives |
| 03/15/2011 | CA2376158C Use of selective estrogen receptor modulators in the manufacture of medicaments for treating and/or suppressing weight gain |
| 03/15/2011 | CA2232191C Inhibition of tumor necrosis factor alpha |
| 03/10/2011 | WO2011028995A1 Compounds as tyrosine kinase modulators |
| 03/10/2011 | WO2011027888A1 Diamide-phenyl derivative and pharmaceutically acceptable salt thereof |
| 03/10/2011 | WO2011026959A1 Novel ethane diamine hepcidin antagonists |
| 03/10/2011 | WO2011026917A1 Heteroaryl compounds as kinase inhibitors |
| 03/10/2011 | WO2011026911A1 Bipyridines useful for the treatment of proliferative diseases |
| 03/10/2011 | WO2011026904A1 Pyrazinylpyridines useful for the treatment of proliferative diseases |
| 03/10/2011 | WO2011026891A1 Substituted pyridine derivatives and their medical use |
| 03/10/2011 | WO2011026890A1 2, 3, 6 -triamino substituted pyridines as kv7 (kcnq) channel modulators |
| 03/10/2011 | WO2011026579A1 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors |
| 03/10/2011 | US20110060024 Modulators of ATP-Binding Cassette Transporters |
| 03/10/2011 | US20110059992 New Compounds |
| 03/10/2011 | US20110059971 Derivatives of 4-aminopiperidine and their use as a medicament |
| 03/10/2011 | US20110059968 Carboxamide compounds and their use as calpain inhibitors |
| 03/10/2011 | US20110059964 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 03/10/2011 | US20110059867 Functionalized polydiacetylene sensors |
| 03/10/2011 | US20110059043 Chemical compounds |
| 03/10/2011 | CA2773038A1 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 03/10/2011 | CA2772790A1 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors |
| 03/10/2011 | CA2772718A1 Compounds as tyrosine kinase modulators |
| 03/10/2011 | CA2772265A1 Pyrazinylpyridines useful for the treatment of proliferative diseases |
| 03/10/2011 | CA2771568A1 Heteroaryl compounds as kinase inhibitors |
| 03/10/2011 | CA2771563A1 Bipyridines useful for the treatment of proliferative diseases |
| 03/09/2011 | EP2292610A1 Macrolides with VEGF transcription suppression activity |
| 03/09/2011 | EP2292228A1 Pyrazole derivatives as 11-beta-HSD1 inhibitors |
| 03/09/2011 | EP2292227A2 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity |
| 03/09/2011 | EP2291365A1 5-substituted isoindoline compounds |
| 03/09/2011 | EP2291354A1 Compound comprising phenyl pyridine units |